Drug-induced lupus erythematosus (DILE)
Bedside summary
Lupus-like syndrome triggered by a culprit drug, resolving after withdrawal. Features arthralgia/arthritis, myalgia, fever, serositis (pleuritis/pericarditis) and constitutional symptoms; renal and CNS involvement are rare (unlike idiopathic SLE). Classic triggers: hydralazine, procainamide, isoniazid, minocycline, anti-TNF agents, quinidine, methyldopa, chlorpromazine, terbinafine, some anticonvulsants and PD-1/PD-L1 checkpoint inhibitors. Serology: ANA positive with ANTI-HISTONE antibodies (hallmark, though anti-TNF-induced lupus may have anti-dsDNA). Normal complement is typical. Recognition hinges on the drug history.
Red flags
- Significant proteinuria/active sediment or neuropsychiatric features — suggests idiopathic SLE, not DILE; reassess
- Large pericardial effusion/tamponade physiology from serositis
- Symptoms persisting weeks after drug withdrawal — reconsider diagnosis
- Checkpoint-inhibitor-related lupus — part of immune-related adverse event spectrum, oncology input
- Anti-TNF-induced lupus — may have anti-dsDNA and need drug-class change
Assessment
Differential diagnosis
- Idiopathic SLE (renal/CNS/haematologic involvement, anti-dsDNA/Sm, low complement)
- Viral/reactive arthritis, other drug reactions
- Rheumatoid arthritis, other CTD
- Infective serositis, malignancy
- Subacute cutaneous lupus (also drug-induced — anti-Ro, photosensitive rash)
Investigations
- Detailed drug/exposure history (timing — usually months of exposure) — the key diagnostic step
- ANA (positive) + ANTI-HISTONE antibodies (characteristic); anti-dsDNA usually negative (except anti-TNF-induced)
- Complement C3/C4 (usually NORMAL — helps distinguish from SLE)
- FBC (cytopenias uncommon), U&E + urinalysis (renal involvement rare — if present reconsider SLE)
- ESR/CRP; CXR/echo if serositis suspected
Management
- Identify and STOP the culprit drug — the definitive treatment; symptoms usually resolve over days to weeks
- Confirm supportive serology (ANA + anti-histone, normal complement, absent major organ disease)
- Symptomatic treatment while resolving: NSAIDs for arthralgia/serositis
- Short course of low-moderate glucocorticoids for significant serositis or disabling symptoms
- Hydroxychloroquine for persistent musculoskeletal/cutaneous symptoms if needed
- Document and flag the drug allergy; avoid re-exposure and related agents
- If features atypical, organ involvement, or symptoms persist beyond weeks — reassess for idiopathic SLE
Drugs & doses
Disposition
Complications & pitfalls
- Serositis (pericarditis/pleuritis) — occasionally significant effusions
- Persistent symptoms if drug not identified
- Rarely, overlap with evolving idiopathic SLE
Exam pearls
- The diagnosis is made on the DRUG HISTORY — ANA + anti-histone antibodies with NORMAL complement and no renal/CNS disease is the classic profile.
- Stopping the drug is curative; symptoms resolve over days to weeks (serology can lag/persist longer).
- Renal and neurological involvement are rare — if present, think idiopathic SLE instead.
- Anti-TNF and checkpoint-inhibitor induced lupus are increasingly common and may break the 'anti-histone/normal complement' rule (can have anti-dsDNA).
- Hydralazine and procainamide are the highest-risk classic culprits (slow acetylators at greater risk).
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.